RC19D2 Cell Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RC19D2 Cell Injection, covering 2024-08-27 to 2024-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma [Phase 1]